%0 Journal Article %A C. K. Sruthi %A Malay Ranjan Biswal %A Brijesh Saraswat %A Himanshu Joshi %A Meher K. Prakash %T Predicting and interpreting COVID-19 transmission rates from the ensemble of government policies %D 2020 %R 10.1101/2020.08.27.20179853 %J medRxiv %P 2020.08.27.20179853 %X Several questions resonate as the governments relax their COVID-19 mitigation policies - is it too early to relax them, were the policies as effective as they could have been. Answering these questions about the past or crafting newer policy decisions in the future requires a quantification of how policy choices affect the spread of the infection. Policy landscape as well as the infection trajectories from different states and countries diverged so fast that comparing and learning from them has not been easy. In this work, we standardize and pool together the ensemble of lockdown and graded re-opening policies adopted by the 50 states of USA in any given week between 9th March and 9th August. Using artificial intelligence (AI) on this pooled data, we build a predictive model (, ) for the weekly-averaged transmission rate of infections. Predictability conceptually raises the possibility of an evidence-based or data-driven mitigation policy-making by evaluating the relative merits of the different policy scenarios. Probing the predictions with interpretable AI highlights how factors such as the closing of bars or the use of masks influence transmission, effects which have been hard to decouple from the ensemble of policy instrument combinations. While acknowledging the limitations of our predictions as well as of the infection testing, we ask the theoretical question if the observed transmission rates in the states were as efficient as they could have been under various levels of restrictions, and if the mitigation policies of the states are ‘overdesigned’. The model can be further refined with a more detailed inclusion of geographies and policy compliances, as well as expanded as newer policies emerge.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding availableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The work is a theoretical work performed with publicly available data on the number of infections. No ethics approval is required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe work is a theoretical work performed with publicly available data on the number of infections. However, the data will be made available upon request. %U https://www.medrxiv.org/content/medrxiv/early/2020/09/01/2020.08.27.20179853.full.pdf